# Magnetic Jejuno-Ileal Diversion Study ("MJI Study")

> **NCT06232746** · NA · COMPLETED · sponsor: **GT Metabolic Solutions, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes

## Interventions

- **DEVICE:** Magnet System, DI Biofragmentable

## Key facts

- **NCT ID:** NCT06232746
- **Lead sponsor:** GT Metabolic Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-13
- **Primary completion:** 2024-09-24
- **Final completion:** 2025-06-24
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06232746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06232746, "Magnetic Jejuno-Ileal Diversion Study ("MJI Study")". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06232746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*